Namwiwat Medical Corporation Past Earnings Performance
Past criteria checks 2/6
Namwiwat Medical has been growing earnings at an average annual rate of 7.9%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 2.1% per year. Namwiwat Medical's return on equity is 8.6%, and it has net margins of 18.1%.
Key information
7.9%
Earnings growth rate
-77.1%
EPS growth rate
Medical Equipment Industry Growth | 12.3% |
Revenue growth rate | -2.1% |
Return on equity | 8.6% |
Net Margin | 18.1% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Namwiwat Medical Corporation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 964 | 174 | 237 | 0 |
30 Jun 24 | 936 | 162 | 226 | 0 |
31 Mar 24 | 1,008 | 168 | 240 | 0 |
31 Dec 23 | 1,103 | 201 | 230 | 0 |
30 Sep 23 | 1,239 | 242 | 152 | 0 |
31 Dec 22 | 1,100 | 176 | 103 | 0 |
31 Dec 21 | 995 | 175 | 115 | 0 |
31 Dec 20 | 679 | 112 | 65 | 0 |
Quality Earnings: NAM-R has high quality earnings.
Growing Profit Margin: NAM-R's current net profit margins (18.1%) are lower than last year (19.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NAM-R's earnings have grown by 7.9% per year over the past 5 years.
Accelerating Growth: NAM-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NAM-R had negative earnings growth (-28%) over the past year, making it difficult to compare to the Medical Equipment industry average (-2.8%).
Return on Equity
High ROE: NAM-R's Return on Equity (8.6%) is considered low.